Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs)

被引:155
作者
Turner, Neil A. [1 ,2 ]
机构
[1] Univ Leeds, Div Cardiovasc & Diabet Res, Leeds, W Yorkshire, England
[2] Univ Leeds, MCRC, Leeds, W Yorkshire, England
关键词
Cardiac fibroblasts; Damage-associated molecular patterns; Inflammation; Fibrosis; Innate immune system; ISCHEMIA-REPERFUSION INJURY; TOLL-LIKE RECEPTORS; TENASCIN-C; ISCHEMIA/REPERFUSION INJURY; NLRP3; INFLAMMASOME; INNATE IMMUNITY; DIABETIC CARDIOMYOPATHY; OXIDATIVE STRESS; MESSENGER-RNA; S100; PROTEINS;
D O I
10.1016/j.yjmcc.2015.11.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac fibroblasts (CF) are well-established as key regulators of extracellular matrix (ECM) turnover in the context of myocardial remodelling and fibrosis. Recently, this cell type has also been shown to act as a sensor of myocardial damage by detecting and responding to damage-associated molecular patterns (DAMPs) upregulated with cardiac injury. CF express a range of innate immunity pattern recognition receptors (TLRs, NLRs, IL-1R1, RAGE) that are stimulated by a host of different DAMPs that are evident in the injured or remodelling myocardium. These include intracellular molecules released by necrotic cells (heat shock proteins, high mobility group box 1 protein, S100 proteins), proinfiammatory cytokines (interleukin-1 alpha), specific ECM molecules up-regulated in response to tissue injury (fibronectin-EDA, tenascin-C) or molecules modified by a pathological environment (advanced glycation end product-modified proteins observed with diabetes). DAMP receptor activation on fibroblasts is coupled to altered cellular function including changes in proliferation, migration, myofibroblast transdifferentiation, ECM turnover and production of fibrotic and inflammatory paracrine factors, which directly impact on the heart's ability to respond to injury. This review gives an overview of the important role played by CF in responding to myocardial DAMPs and how the DAMP/CF axis could be exploited experimentally and therapeutically. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:189 / 200
页数:12
相关论文
共 157 条
[1]  
Abbate A., 2013, AM J CARDIOL
[2]   Alterations in the Interleukin-1/Interleukin-1 Receptor Antagonist Balance Modulate Cardiac Remodeling following Myocardial Infarction in the Mouse [J].
Abbate, Antonio ;
Salloum, Fadi N. ;
Van Tassell, Benjamin W. ;
Vecile, Elena ;
Toldo, Stefano ;
Seropian, Ignacio ;
Mezzaroma, Eleonora ;
Dobrina, Aldo .
PLOS ONE, 2011, 6 (11)
[3]   Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study) [J].
Abbate, Antonio ;
Kontos, Michael C. ;
Grizzard, John D. ;
Biondi-Zoccai, Giuseppe G. L. ;
Van Tassell, Benjamin W. ;
Robati, Roshanak ;
Roach, Lenore M. ;
Arena, Ross A. ;
Roberts, Charlotte S. ;
Varma, Amit ;
Gelwix, Christopher C. ;
Salloum, Fadi N. ;
Hastillo, Andrea ;
Dinarello, Charles A. ;
Vetrovec, George W. .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (10) :1371-1377
[4]   RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model [J].
Aleshin, Alexey ;
Ananthakrishnan, Radha ;
Li, Qing ;
Rosario, Rosa ;
Lu, Yan ;
Qu, Wu ;
Song, Fei ;
Bakr, Soliman ;
Szabolcs, Matthias ;
D'Agati, Vivette ;
Liu, Rui ;
Homma, Shunichi ;
Schmidt, Ann Marie ;
Yan, Shi Fang ;
Ramasamy, Ravichandran .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 294 (04) :H1823-H1832
[5]   High-mobility group box-1 in ischemia-reperfusion injury of the heart [J].
Andrassy, Martin ;
Volz, Hans C. ;
Igwe, John C. ;
Funke, Benjamin ;
Eichberger, Sebastian N. ;
Kaya, Ziya ;
Buss, Sebastian ;
Autschbach, Frank ;
Pleger, Sven T. ;
Lukic, Ivan K. ;
Bea, Florian ;
Hardt, Stefan E. ;
Humpert, Per M. ;
Bianchi, Marco E. ;
Mairbaeurl, Heimo ;
Nawroth, Peter P. ;
Remppis, Andrew ;
Katus, Hugo A. ;
Bierhaus, Angelika .
CIRCULATION, 2008, 117 (25) :3216-3226
[6]   Treatment With OPN-305, a Humanized Anti-Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/Reperfusion Injury in Pigs [J].
Arslan, Fatih ;
Houtgraaf, Jaco H. ;
Keogh, Brian ;
Kazemi, Kushan ;
de Jong, Renate ;
McCormack, William J. ;
O'Neill, Luke A. J. ;
McGuirk, Peter ;
Timmers, Leo ;
Smeets, Mirjam B. ;
Akeroyd, Lars ;
Reilly, Mary ;
Pasterkamp, Gerard ;
de Kleijn, Dominique P. V. .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (02) :279-287
[7]   Innate immune signaling in cardiac ischemia [J].
Arslan, Fatih ;
de Kleijn, Dominique P. ;
Pasterkamp, Gerard .
NATURE REVIEWS CARDIOLOGY, 2011, 8 (05) :292-300
[8]   Lack of Fibronectin-EDA Promotes Survival and Prevents Adverse Remodeling and Heart Function Deterioration After Myocardial Infarction [J].
Arslan, Fatih ;
Smeets, Mirjam B. ;
Vis, Paul W. Riem ;
Karper, Jacco C. ;
Quax, Paul H. ;
Bongartz, Lennart G. ;
Peters, John H. ;
Hoefer, Imo E. ;
Doevendans, Pieter A. ;
Pasterkamp, Gerard ;
de Kleijn, Dominique P. .
CIRCULATION RESEARCH, 2011, 108 (05) :582-U110
[9]   Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti-Toll-Like Receptor-2 Antibody [J].
Arslan, Fatih ;
Smeets, Mirjam B. ;
O'Neill, Luke A. J. ;
Keogh, Brian ;
McGuirk, Peter ;
Timmers, Leo ;
Tersteeg, Claudia ;
Hoefer, Imo E. ;
Doevendans, Pieter A. ;
Pasterkamp, Gerard ;
de Kleijn, Dominique P. V. .
CIRCULATION, 2010, 121 (01) :80-90
[10]   Toll-Like Receptor 4 Stimulation Initiates an Inflammatory Response That Decreases Cardiomyocyte Contractility [J].
Avlas, Orna ;
Fallach, Reut ;
Shainberg, Asher ;
Porat, Eyal ;
Hochhauser, Edith .
ANTIOXIDANTS & REDOX SIGNALING, 2011, 15 (07) :1895-1909